LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/People In The News/Brad Mason Joins Aurora Spine
People In The News

Brad Mason Joins Aurora Spine

November 21, 2012 1 min read Premium comments

Advertisement

Brad Mason Joins Aurora Spine
Brad Mason

The former group president of Orthofix International NV and principal founder of BREG, Inc., has accepted the position of Chairman to the Advisory Board of Aurora Spine, LLC. Brad Mason assumed his new responsibilities with the Carlsbad, California, company on October 25, 2012.

While Mason was chairman and CEO of BREG, Inc., a sports medicine orthopedics company, the firm grossed nearly $100 million in sales. Before his retirement, Mason was group president for North America for Orthofix International NV, a $550 million publicly traded, multinational orthopedic device manufacturing company.

We are honored to have Brad Mason join Aurora Spine as he brings a unique perspective to our leadership team. His experience and insight are incredibly valuable as we work to further establish Aurora’s position in the orthopedic spine industry, ” said Trent Northcuff, CEO of Aurora Spine. “We look forward to drawing on the depth of his knowledge and business expertise as we launch our disruptive MIS technology in the first quarter of 2013.

Aurora Spine specializes in minimally-invasive (MIS) regenerative technologies.

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy